Gilead Brings In Sanofi’s Dietmar Berger To Reset Drug Development

 
• By Andrew McConaghie
  
Gilead
Gilead adds in liver with CymaBay acquisition • Source: Shutterstock: Tada Images

More from Executives On The Move

More from Scrip